Familial Hemophagocytic Lymphohistiocytosis: Too Little Cell Death Can Seriously Damage Your Health

References

• Jacobson M. D., Weil M., Raff M. C. Programmed cell death in animal development. Cell 1997; 88: 347–354
   PubMed Web of Science ®Google Scholar
• Fadeel B., Orrenius S., Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony?. Biochemical and Biophysical Research Communications 1999; 266: 699–717
   PubMed Web of Science ®Google Scholar
• Los M., Wesselborg S., Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 1999; 10: 629–639
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365
   PubMed Web of Science ®Google Scholar
• Farquhar J. W., Claireaux A. E. Familial hemophagocytic reticulosis. Archives of Disease in Childhood 1952; 27: 519–525
   PubMed Web of Science ®Google Scholar
• Henter J-I., Aricò M., Elinder G., Imashuku S., Janka G. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematology/Oncology Clinics of North America 1998; 12: 417–433
   PubMed Web of Science ®Google Scholar
• Fischer A., Cavazzana-Calvo M., de Saint Basile G., DeV-Illartay J. P., Di Santo J. P., Hivroz C., Rieux-Laucat F., Le Deist F. Naturally occurring primary deficiencies of the immune system. Annual Review of Immunology 1997; 15: 93–124
   PubMed Web of Science ®Google Scholar
• Arceci R. J. The histiocytoses: the fall of the Tower of Babel. European Journal of Cancer 1999; 35: 747–769
   PubMed Web of Science ®Google Scholar
• Janka G. E. Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics 1983; 140: 221–230
   PubMed Web of Science ®Google Scholar
• Henter J-I., Elinder G., Öst Å., FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminars in Oncology 1991; 18: 29–33
   PubMed Web of Science ®Google Scholar
• Henter J-I., Aricò M., Egeler R. M., Elinder G., Favara B. E., Filipovich A. H., Gadner H., Imashuku S., Janka-Schaub G., Komp D., Ladisch S., Webb D., HLH study group of the Histiocyte Society. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology 1997; 28: 342–347
   PubMedGoogle Scholar
• Henter J-I., Nennesmo I. Neuropathological findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. Journal of Pediatrics 1997; 130: 358–365
   PubMed Web of Science ®Google Scholar
• Haddad E., Sulis M-L., Jabado N., Blanche S., Fischer A., Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 794–800
   PubMed Web of Science ®Google Scholar
• Fischer A., Cerf-Bensussan N., Blanche S., Le Deist F., Bremard-Oury C., Leverger G., Schaison G., Durandy A., Griscelli C. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. Journal of Pediatrics 1986; 108: 267–270
   PubMed Web of Science ®Google Scholar
• Jabado N., de Graeff-Meeder E. R., Cavazzana-Calvo M., Haddad E., Le Deist F., Benkerrou M., Dufourcq R., Caillat S., Blanche S., Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantion from HLA genetically nonidentical donors. Blood 1997; 90: 4743–4748
   PubMed Web of Science ®Google Scholar
• Durken M., Horstmann M., Bieling P., Ertmann R., Kabisch H., Loliger C., Schneider E. M., Hellwege H. H., Kruger W., Kroger N., Zander A. R., Janka G. E. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. British Journal of Haematology 1999; 106: 1052–1058
   PubMed Web of Science ®Google Scholar
• Henter J-I., Ehrnst A., Andersson J., Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatrica 1993; 82: 369–372
   PubMed Web of Science ®Google Scholar
• Hoang M. P., Dawson D. B., Rogers Z. R., Scheuerman R. H., Rogers B. B. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Human Pathology 1998; 29: 1074–1077
   PubMed Web of Science ®Google Scholar
• Janka G., Imashuku S., Elinder G., Schneider M., Henter J-I. Infection-and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic syndromes. Hematology/Oncology Clinics of North America 1998; 12: 435–444
   PubMed Web of Science ®Google Scholar
• Dufourcq-Lagelouse R., Pastural E., Barrat F. J., Feldmann J., Le Deist F., Fischer A., de Saint Basile G. Genetic basis of hemophagocytic lymphohistiocytosis syndrome. International Journal of Molecular Medicine 1999; 4: 127–133
   PubMed Web of Science ®Google Scholar
• Grunebaum E., Zhang J., Dadi H., Roifman C. M. Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency. British Journal of Haematology 2000; 108: 834–837
   PubMed Web of Science ®Google Scholar
• Komp D. M., McNamara J., Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Blood 1989; 73: 2128–2132
   PubMed Web of Science ®Google Scholar
• Henter J-I., Elinder G., Söder O., Hansson M., Andersson B., Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918–2922
   PubMed Web of Science ®Google Scholar
• Imashuku S., Ikushima S., Esumi N., Todo S., Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leukemia and Lymphoma 1991; 3: 287–292
   PubMed Web of Science ®Google Scholar
• Fujiwara F., Hibi S., Imashuku S. Hypercytokinemia in hemophagocytic syndrome. American Journal of Pediatric Hematology and Oncology 1993; 15: 92–98
   PubMedGoogle Scholar
• Imashuku S., Hibi S., Fujiwara F., Todo S. Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis. British Journal of Haematology 1996; 93: 803–807
   PubMed Web of Science ®Google Scholar
• Hagberg B., Hultquist G., Svennerholm L., Voss H. Malignant hyperlipemia in infancy. American Journal of Diseases in Childhood 1964; 107: 267–276
   PubMedGoogle Scholar
• Landrieu P., Choulot J. J. Hemophagocytic reticulosis with hypertriglyceridemia. Archives Francaises De Pediatrie 1976; 33: 497–503
   PubMedGoogle Scholar
• Ladisch S., Poplack D. G., Holiman B., Blaese R. M. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet 1978; 1: 581–583
   PubMed Web of Science ®Google Scholar
• Henter J-I., Carlson L. A., Söder O., Nilsson-Ehle P., Elinder G. Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis. Acta Paediatrica Scandinavica 1991; 80: 675–681
   PubMed Web of Science ®Google Scholar
• Drappa J., Vaishnaw A. K., Sullivan K. E., Chu J.-L., Elkon K. B. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. New England Journal of Medicine 1996; 335: 1643–1649
   PubMed Web of Science ®Google Scholar
• Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middelton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935–946
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I. A.G., Debatin K-M., Fischer A., de Villartay J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347–1349
   PubMed Web of Science ®Google Scholar
• Wang J., Zheng L., Lobito A., Chan F.K-M., Dale J., Sneller M., Yao X., Puck J. M., Straus S. E., Lenardo M. J. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98: 47–58
   PubMed Web of Science ®Google Scholar
• Wu J., Wilson J., He J., Xiang L., Schur P. H., Mountz J. D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. Journal of Clinical Investigation 1996; 98: 1107–1113
   PubMed Web of Science ®Google Scholar
• Parijs L., Abbas A. K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280: 243–248
   PubMed Web of Science ®Google Scholar
• Henter J-I., Andersson B., Elinder G., Jakobson Å., Lübeck P-O., Söder O. Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology 1996; 27: 21–25
   PubMedGoogle Scholar
• Fadeel B., Orrenius S., Henter J-I. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. British Journal of Haematology 1999; 106: 406–415
   PubMed Web of Science ®Google Scholar
• Haas J. P., Grunke M., Frank C., Kolowos W., Dirnecker D., Leipold G., Hieronymus T., Lorenz H-M., Herrmann M. Increased spontaneous in vitro apoptosis in double negative T cells of humans with afas/apo-1 mutation. Cell Death and Differentiation 1998; 5: 751–757
   PubMed Web of Science ®Google Scholar
• Fischer A., Rieux-Laucat F., Le Deist F. A new peak in the ALPS. Nature Medicine 1999; 5: 876–877
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F., Blachere S., Danielan S., De Villartay J. P., Oleastro M., Solary E., Bader-Meunier B., Arkwright P., Pondare C., Bernaudin F., Chapel H., Nielsen S., Berrah M., Fischer A., Le Deist F. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999; 94: 2575–2582
   PubMed Web of Science ®Google Scholar
• Berke G. The CTL's kiss of death. Cell 1995; 81: 9–12
   PubMed Web of Science ®Google Scholar
• Trapani J. A., Sutton V. R., Smyth M. J. CTL granules: evolution of vesicles essential for combating virus infections. Immunology Today 1999; 20: 351–356
   PubMedGoogle Scholar
• Nicholson D. W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death and Differentiation 1999; 6: 1028–1042
   PubMed Web of Science ®Google Scholar
• Andrade F., Roy S., Thornberry N., Rosen A., Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 1998; 8: 451–460
   PubMed Web of Science ®Google Scholar
• Thomas D. A., Du C., Xu M., Wang X., Ley T. J. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity 2000; 12: 621–632
   PubMed Web of Science ®Google Scholar
• Shresta S., Pham C. T.N., Thomas D. A., Graubert T. A., Ley T. J. How do cytotoxic lymphocytes kill their targets?. Current Opinion in Immunology 1998; 10: 581–587
   PubMed Web of Science ®Google Scholar
• Biron C. A., Byron K. S., Sullivan J. L. Severe herpesvirus infections in an adolescent without natural killer cells. New England Journal of Medicine 1989; 320: 1731–1735
   PubMed Web of Science ®Google Scholar
• Holtmann H., Janka G. E., Weidner E., Eife R. Impaired natural killer cell function in familial hemophagocytic lymphohistiocytosis. Immunobiology 1982; 162: 364–371
   Web of Science ®Google Scholar
• Perez N., Virelizier J. L., Arenzana-Seisdedos F., Fischer A., Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. Journal of Pediatrics 1984; 104: 569–573
   PubMed Web of Science ®Google Scholar
• Aricò M., Nespoli L., Maccario R., Montagna D., Bonetti F., Caselli D., Burgio G. R. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Archives of Disease in Childhood 1988; 63: 292–296
   PubMed Web of Science ®Google Scholar
• Eife R., Janka G. E., Belohradsky B. H., Holtmann H. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatric Hematology and Oncology 1989; 6: 265–272
   PubMed Web of Science ®Google Scholar
• Egeler R. M., Shapiro R., Loechelt B., Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/Oncology 1996; 18: 340–345
   PubMed Web of Science ®Google Scholar
• Sullivan K. E., Delaat C. A., Douglas S. D., Filipovich A. H. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatric Research 1998; 44: 465–468
   PubMed Web of Science ®Google Scholar
• Blanche S., Caniglia M., Girault D., Landman J., Griscelli C., Fischer A. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood 1991; 78: 51–54
   PubMed Web of Science ®Google Scholar
• Hasegawa D., Kojima S., Tatsumi E., Hayakawa A., Kosaka Y., Nakamura H., Sako M., Osugi Y., Nagata S., Sano K. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 1998; 91: 2793–2799
   PubMed Web of Science ®Google Scholar
• Ohadi M., Lalloz M. R.A., Sham P., Zhao J., Dearlove A. M., Shiach C., Kinsey S., Rhodes M., Layton D. M. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. American Journal of Human Genetics 1999; 64: 165–171
   PubMed Web of Science ®Google Scholar
• Dufourcq-Lagelouse R., Jabado N., Le Deist F., Stéphan J-L., Souillet G., Bruin M., Vilmer E., Schneider M., Janka G., Fischer A., de Saint Basile G. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21–22 and evidence for heterogeneity. American Journal of Human Genetics 1999; 64: 172–179
   PubMed Web of Science ®Google Scholar
• Stepp S. E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P. A., Henter J-I., Bennett M., Fischer A., de Saint Basile G., Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957–1959
   PubMed Web of Science ®Google Scholar
• Baetz K., Isaaz S., Griffiths G. M. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. Journal of Immunology 1995; 154: 6122–6131
   PubMed Web of Science ®Google Scholar
• Stepp S. E., Mathew P. A., Bennett M., de Saint Basile G., Kumar V. Perforin: more than just an effector molecule. Immunology Today 2000; 21: 254–256
   PubMedGoogle Scholar
• Raff M. C. Social controls on cell survival and cell death. Nature 1992; 356: 397–400
   PubMed Web of Science ®Google Scholar